DTL
CBIO

Dynamic Technology Lab’s Crescent Biopharma CBIO Stock Holding History

Dynamic Technology Lab’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-112
Closed -$42K – 1118
2020
Q2 		$42K Buy
+112
New +$31.7K 0.01% 927
2020
Q1 		– Sell
-119
Closed -$63K – 1151
2019
Q4 		$63K Buy
+119
New +$64.4K 0.01% 909
2017
Q4 		– Sell
-190
Closed -$265K – 1120
2017
Q3 		$265K Buy
190
+58
+44% +$68.1K 0.04% 783
2017
Q2 		$146K Buy
+132
New +$109K 0.03% 916

Other funds holding CBIO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.34B AUM 204.53% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $718M AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return